Clinical characteristics and outcomes of B-cell precursor ALL with MEF2D rearrangements: a retrospective study by the Ponte di Legno Childhood ALL Working Group

Affiliations

• ¹ Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan.
• ² Leukaemia Research Cytogenetics Group, Wolfson Childhood Cancer Research Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
• ³ Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
• ⁴ Hannover Medical School, Institute of Human Genetics, Hannover, Germany.
• ⁵ Department of Pediatrics, Christian-Albrechts-University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany.
• ⁶ Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.
• ⁷ Oncode Institute, Utrecht, The Netherlands.
• ⁸ Department of Genetics, Robert Debré Hospital and Université Paris Cité, Paris, France.
• ⁹ Centro Ricerca Tettamanti, Pediatrics, University of Milano Bicocca, Monza, Italy.
• ¹⁰ Medical Genetics, School of Medicine and Surgery, University of Milano Bicocca, Monza, Italy.
• ¹¹ Khoo Teck Puat - National University Children's Medical Institute, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
• ¹² Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
• ¹³ Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
• ¹⁴ Department of Oncology, St Jude Children's Research Hospital, Memphis, TN, USA.
• ¹⁵ Department of Pathology, St Jude Children's Research Hospital, Memphis, TN, USA.
• ¹⁶ Department of Pediatrics, Benioff Children's Hospital and the Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
• ¹⁷ Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden.
• ¹⁸ Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou and Chang Gung University, Taoyuan, Taiwan.
• ¹⁹ CLIP, Department of Paediatric Haematology/Oncology, Second Faculty of Medicine of Charles University Prague and University Hospital Motol, Prague, Czech Republic.
• ²⁰ Children's Cancer Research Institute, Vienna, Austria.
• ²¹ Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo, Japan. atmanabe@med.hokudai.ac.jp.